ApolloMed Q2 revenue up 29% to $348.2M, net income +10%; guidance reaffirmed

Astrana Health, Inc.

2023-Q2 EPS reported $0.56 revenue$685,453,000

Total revenue $348.2M (+29% YoY); net income attributable to ApolloMed $13.2M (+10%); adjusted EBITDA $35.8M (+44%).
Care Partners revenue $325.2M (+32%); segment operating income surged 250% to $27.8M.
FY2023 guidance reaffirmed: total revenue $1.3B-$1.5B; adjusted EBITDA $120M-$160M; diluted EPS $0.95-$1.20.
Agreed to acquire Texas Independent Providers (120+ PCPs); partnered with IntraCare (425+ providers) with $25M convertible note.
Filing corrects balance sheet items: income taxes payable to $20.4M, total liabilities to $443.6M, mezzanine equity to $13.8M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Astrana Health, Inc. reported six months ended June 30, 2023 results: revenue $685.5 million, net income $26.3 million. Guidance reaffirmed.

Period: six months ended June 30, 2023
Revenue: $685.5 million
Net income: $26.3 million
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Financial Highlights for Six Months Ended June 30, 2023: All comparisons are to the six months ended June 30, 2022 unless otherwise stated. • Total revenue of $685.5 million, up 29% from $533.0 million • Care Partners revenue of $639.9 million, up 31% from $488.6 million • Net income attributable to ApolloMed of $26.3 million, up 2% from $25.7 million

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Astrana Health, Inc. reported second quarter ended June 30, 2023 results: revenue $348.2 million, net income $13.2 million. Guidance reaffirmed.

Period: second quarter ended June 30, 2023
Revenue: $348.2 million
Net income: $13.2 million
Guidance: reaffirmed
Result: reported results

Exact text from the filing

full-year 2023.” Financial Highlights for Second Quarter Ended June 30, 2023: All comparisons are to the quarter ended June 30, 2022 unless otherwise stated. • Total revenue of $348.2 million, up 29% from $269.7 million • Care Partners revenue of $325.2 million, up 32% from $247.3 million • Net income attributable to ApolloMed of $13.2 million, up 10% from $12.0

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Astrana Health, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-089366

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.